Last reviewed · How we verify
The Effect of Vaginal Mifepristone on Reduction of Uterine Fibroids Size and the Symptoms Associated With the Fibroids - Pilot Study (Phase IIa)
The purpose of this study is to evaluate the effect of daily dosage of vaginally mifepristone on reduction of uterine fibroids size and the symptoms associated with uterine fibroids.
Details
| Lead sponsor | BioPro Medical Ltd |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | 2009-04 |
| Completion | 2012-07 |
Conditions
- Uterine Fibroid
- Vaginal Bleeding.
Interventions
- mifepristone vaginal tablets
Primary outcomes
- Decrease of uterine fibroids volume by 25% and up. — 1 year
Countries
Israel